Rabavert rabies vacc w-diluents
Ended Awarded
- Contract number
- SPE2DB25FRN31
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,910
Award facts
- Contract value 100% obligated
- $19,910.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,910.10 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 21, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award is issued as a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government health organizations. The company's extensive federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements across diverse therapeutic domains, including vaccines, specialty medications, and medical supplies. This rabies vaccine delivery order represents a routine procurement fulfilling the DLA's ongoing medical supply needs through AmerisourceBergen's established prime vendor relationship.
Quick answers
Who was awarded contract SPE2DB25FRN31?
SPE2DB25FRN31 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FRN31 worth?
The government has obligated $19,910 on SPE2DB25FRN31.
Is contract SPE2DB25FRN31 an order under another contract?
Yes. SPE2DB25FRN31 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRN31 competed?
The extent of competition for SPE2DB25FRN31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award